Kidney function after liver transplantation: the contrasting roles of inflammation and tubular repair.
OPN
TIMP-1
acute kidney injury
hepatorenal
liver transplant
tubular cell
Journal
Frontiers in transplantation
ISSN: 2813-2440
Titre abrégé: Front Transplant
Pays: Switzerland
ID NLM: 9918573988006676
Informations de publication
Date de publication:
2024
2024
Historique:
received:
13
08
2024
accepted:
19
09
2024
medline:
23
10
2024
pubmed:
23
10
2024
entrez:
23
10
2024
Statut:
epublish
Résumé
Kidney injury is a significant complication in end-stage liver disease (ESLD), leading to increased morbidity and mortality. While liver transplant alone (LTA) can promote kidney recovery (KR), non-recovery associates with adverse outcomes, but the underlying pathophysiology is still unclear. We studied 10 LTA recipients with or without kidney failure (KF) and measured serum levels of OPN and TIMP-1 (previously identified predictors of KR), 92 proinflammatory proteins (Olink), and urinary cell populations. Our findings revealed elevated OPN and TIMP-1 levels in KF patients, strongly correlated with tubular epithelial cells in urine. Proteomic analysis showed distinct profiles in KF, non-KF, and healthy donors, indicating an ongoing proinflammatory signature in KF. Cytokines correlated with OPN and TIMP-1 levels. We propose that high pre-LTA OPN and TIMP-1 levels are crucial for tubular regeneration and normalize with kidney recovery. Insufficient pre-LTA OPN levels may lead to persistent kidney failure. Our present data also newly indicate that kidney failure post-LTA is an active condition, in which tubular cells are persistently shed in the urine. The strict association between systemic inflammation and tubular cell loss suggests a pathogenic link that could offer therapeutic opportunities to promote kidney recovery.
Identifiants
pubmed: 39440014
doi: 10.3389/frtra.2024.1480383
pmc: PMC11493771
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1480383Informations de copyright
© 2024 Goerlich, Kim-Schulze, Kotanko, Grobe, Wang, Samans, Douglas, Enghard, Molinari, Fribourg, Cravedi and Levitsky.
Déclaration de conflit d'intérêts
PE holds a patent for preservation or urine cells (CHA124WOEP-UP). BS is employed at Precision for Medicine, a company offering molecular biology services. JD was employed by company Eurofins Viracor. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.